Article
AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor…
Molecular therapy. Oncology · 2024 · N. An, K. Chen, G. Li, T. Ye, J. Yu, G. Zhang, Y. Zhou, J. Zhu, B. Zhu
Key facts
| Title | AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer. |
|---|---|
| First author | N. An, K. Chen, G. Li, T. Ye, J. Yu, G. Zhang, Y. Zhou, J. Zhu, B. Zhu |
| Journal | Molecular therapy. Oncology |
| Published | Sep 17, 2024 |
| DOI | 10.1016/j.omton.2024.200878 |
| PubMed ID | 39431173 |
| PMC ID | PMC11488421 |
| Devices mentioned | 200878 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1